<DOC>
	<DOCNO>NCT01647360</DOCNO>
	<brief_summary>Dydrogesterone retroprogesterone molecular structure similar natural progesterone . As C-21 steroid , high affinity progesterone receptor , low antigonadotropic activity antiestrogenic activity , almost estrogenic androgenic activity . Dydrogesterone ( DuphastonÂ© ) indicate dysfunctional bleeding . In study , woman suffer menorrhagia treat dydrogesterone observe impact QoL reduction severity bleeding .</brief_summary>
	<brief_title>Severity Bleeding Predictor Quality Life ( QoL ) Women With Heavy Menstrual Bleeding ( HMB ) Under Dydrogesterone Treatment</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Menorrhagia</mesh_term>
	<mesh_term>Metrorrhagia</mesh_term>
	<mesh_term>Dydrogesterone</mesh_term>
	<criteria>Inclusion Criteria Females age 18 45 year Subjects present Heavy Menstrual Bleeding ( HMB ) Subjects Pictorial Blood Assessment Chart ( PBAC ) score 100 Subjects treat dydrogesterone accordance local label enrollment trial Exclusion Criteria Subjects structural organic pathology underlie cause HMB . Subjects hypersensitivity dydrogesterone Known suspect progestogen dependent neoplasms Subjects vaginal bleeding screen organic structural pathology underlie cause Subjects acute chronic liver disease Patients depressive illness Subjects know rare hereditary problem galactose intolerance , Lapp lactase deficiency glucosegalactose malabsorption Nursing mother Use medication uterine bleeding ( include limit progesterone , oral contraceptive pill , tranexamic acid etc ) Use NonSteroidal Anti inflammatory Drugs ( NSAIDs )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Metrorrhagia</keyword>
	<keyword>Menorrhagia</keyword>
</DOC>